Bridging Cardiorenal and Hepatic Disease: The Emerging Role of SGLT2 Inhibitors in Cirrhosis
Sodium–glucose cotransporter-2 inhibitors improve kidney and cardiovascular outcomes through proximal tubular effects that produce osmotic diuresis, modest natriuresis, and rest...